oclacitinib maleate
zoetis australia pty ltd - oclacitinib maleate - unknown - oclacitinib maleate active 0.0 - active constituent
oclacitinib maleate
zoetis australia pty ltd - oclacitinib maleate - unknown - oclacitinib maleate active 0.0 - active constituent
apoquel- oclacitinib maleate tablet, coated
zoetis inc. - oclacitinib maleate (unii: von733l42a) (oclacitinib - unii:99gs5xtb51) - oclacitinib maleate 3.6 mg - control of pruritus associated with allergic dermatitis and control of atopic dermatitis in dogs at least 12 months of age.
oclacitinib maleate
zoetis australia pty ltd - oclacitinib maleate - unknown - oclacitinib maleate active 0.0 - active constituent
apoquel 16 mg tablets for dogs
zoetis australia pty ltd - oclacitinib maleate - oral tablet - oclacitinib maleate active 16.0 mg/tb - antipruritic
apoquel
zoetis belgium sa - oclacitinib maleate - agents for dermatitis, excluding corticosteroids - dogs - - treatment of pruritus associated with allergic dermatitis in dogs.- treatment of clinical manifestations of atopic dermatitis in dogs.
apoquel 3.6 mg tablets for dogs
zoetis australia pty ltd - oclacitinib maleate - oral tablet - oclacitinib maleate active 3.6 mg/tb - antipruritic
apoquel 5.4 mg tablets for dogs
zoetis australia pty ltd - oclacitinib maleate - oral tablet - oclacitinib maleate active 5.4 mg/tb - antipruritic
apoquel
zoetis new zealand limited - oclacitinib maleate - oclacitinib maleate 48.38 g/kg - anti-inflammatory
apoquel 16 mg veterinary
zoetis israel holding b.v., israel - oclacitinib maleate - film coated tablets - oclacitinib maleate 16 mg - control of pruritus associated with allergic dermatitis and control of atopic dermatitis in dogs at least 12 months of age.